CPT 81362 HBB Familial Test Reimbursement

Headline: CPT code 81362 covers targeted familial testing of the HBB gene

Lead: CPT code 81362 describes a technical laboratory procedure to detect specific hereditary variants in the hemoglobin, subunit beta (HBB) gene identified in a patient’s family. This focused molecular test supports diagnosis, carrier detection, and family planning decisions when a known familial HBB variant is under evaluation.

What the code represents and why it matters: CPT code 81362 designates a targeted, familial-variant molecular test limited to known HBB gene changes. Nationally, such precise genetic testing reduces unnecessary broad-panel testing, enables quicker results for affected families, and informs clinical management for hemoglobinopathy risk.

Key payers covered: This analysis references coverage and benchmarking considerations for Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

What readers will learn: The publication summarizes the clinical context for familial HBB testing, typical laboratory and site-of-service settings, coverage landscape highlights for major payers, and commonly applied billing modifiers. It also outlines where to find related policy language and coding considerations for technical-component testing in molecular diagnostics.

Scope: Content is national in scope and intended for coding professionals, lab managers, and policy analysts seeking a concise reference for CPT code 81362.

Billing Code Overview

CPT code 81362 describes a laboratory procedure in which a lab analyst performs the technical testing to detect the presence of specific changes in the hemoglobin, subunit beta (HBB) gene for genetic variants known to occur in the patient’s family. This is a targeted familial variant molecular test focused on the HBB gene.

Service type: Targeted familial molecular genetic testing (technical component).
Typical site of service: Clinical molecular diagnostics laboratory or specialized genetics laboratory (reference laboratory or hospital-based molecular lab).

Data not available in the input.

Clinical Context

A 28-year-old person with a family history of beta globin gene variants (HBB) presents after cascade testing was recommended because a sibling was diagnosed with a beta-globin hemoglobinopathy. The ordering clinician documents the specific familial HBB variant(s) to be targeted. A genetic counselor or hematologist obtains informed consent and a peripheral blood or saliva sample is collected at an outpatient phlebotomy clinic or genetics office. The specimen is sent to a molecular diagnostics laboratory where a laboratory analyst performs a targeted molecular assay to detect the presence or absence of the specified familial HBB variant(s). Results are reported to the ordering provider and genetic counselor for carrier status determination, reproductive counseling, or clinical management. Typical site of service: outpatient genetics clinic, hospital outpatient phlebotomy, commercial reference laboratory, or physician office with specimen transport to the lab.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the professional (interpretive) component if the lab and reporting physician bill separately.
`TC`	Technical component

Taxonomy Code	Specialty	Notes
207Q00000X	Clinical Molecular Genetics	Specialty performing molecular genetic testing and interpretation.
2080P0005X	Clinical Pathology	Physician oversight for laboratory testing and result sign-out.
207RG0100X	Genetic Counseling	Ordering and post-test counseling for familial variant testing.
207L00000X	Clinical Laboratory	Laboratory professionals performing technical testing and analysis.
2085R0201X	Hematology	Hematologists ordering or interpreting results in context of hemoglobinopathies.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D56.0`	Beta thalassemia	Targeted familial HBB testing is directly relevant for diagnosis, carrier detection, and reproductive counseling.
`D56.1`	Thalassemia trait, Hb-variant	Used when assessing carrier status for known familial HBB variants.
`Z14.0`	Genetic carrier screening and testing	Indicates purpose of testing when performed for known family variant detection.
`Z15.2`	Genetic susceptibility to other disease (hemoglobinopathy)	Used when documenting known family history of hemoglobinopathy that prompts targeted testing.
`Z83.1`	Family history of other endocrine, nutritional and metabolic diseases (family history of hemoglobinopathies)	Used to document family history prompting cascade testing.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`81220`	HBB (hemoglobin, subunit beta) gene analysis; common variants (eg, sequencing or targeted mutation analysis)	May be used for broader HBB analysis when full gene sequencing or common variant panels are required beyond a single familial variant targeted by `81362`.
`81221`	HBB (hemoglobin, subunit beta) gene analysis; common deletions/duplications	Relevant when testing for larger deletions or duplications in HBB not detectable by single-variant targeted assays.
`81479`	Unlisted molecular pathology procedure	Used when a specific targeted familial test does not exactly match established codes and an unlisted code is needed for billing, with documentation.
`88360`	Morphometric analysis (may apply if special pathology correlation performed)	Rarely used in direct relation but may accompany pathology workflows when tissue-based analyses require correlation.
`80500`	Genetic test administration (specimen handling) — Data not standard; if not applicable, use laboratory-specific administrative codes	Used in some workflows for specimen handling or administrative billing in certain payor arrangements.

OpenPayer

Summary & Overview

CPT 81362: Familial Variant Testing of HBB Gene